These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 23336697)

  • 1. Mucopolysaccharidosis type III (Sanfilippo syndrome) and misdiagnosis of idiopathic developmental delay, attention deficit/hyperactivity disorder or autism spectrum disorder.
    Wijburg FA; Węgrzyn G; Burton BK; Tylki-Szymańska A
    Acta Paediatr; 2013 May; 102(5):462-70. PubMed ID: 23336697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From hypertransaminasemia to mucopolysaccharidosis IIIA.
    Krawiec P; Pac-Kożuchowska E; Mełges B; Mroczkowska-Juchkiewicz A; Skomra S; Pawłowska-Kamieniak A; Kominek K
    Ital J Pediatr; 2014 Dec; 40():97. PubMed ID: 25439061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sanfilippo Syndrome].
    Osipova LA; Kuzenkova LM; Namazova-Baranova LS; Gevorkyan AK; Podkletnova TV; Vashakmadze ND
    Vestn Ross Akad Med Nauk; 2015; (4):419-27. PubMed ID: 26710524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperactivity, unexplained speech delay, and coarse facies--is it Sanfilippo syndrome?
    Saini AG; Singhi P; Sahu JK; Ganesan SL; Vyas S; Rao S; Sachdeva MU
    J Child Neurol; 2014 Aug; 29(8):NP9-12. PubMed ID: 23761035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptoms of Autism Spectrum Disorder (ASD) in Individuals with Mucopolysaccharide Disease Type III (Sanfilippo Syndrome): A Systematic Review.
    Wolfenden C; Wittkowski A; Hare DJ
    J Autism Dev Disord; 2017 Nov; 47(11):3620-3633. PubMed ID: 28856504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sanfilippo syndrome: Overall review.
    Andrade F; Aldámiz-Echevarría L; Llarena M; Couce ML
    Pediatr Int; 2015 Jun; 57(3):331-8. PubMed ID: 25851924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in maladaptive behaviors from midchildhood to young adulthood in autism spectrum disorder.
    Anderson DK; Maye MP; Lord C
    Am J Intellect Dev Disabil; 2011 Sep; 116(5):381-97. PubMed ID: 21905806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of ESSENCE for preschool children with neurodevelopmental disorders.
    Neville B
    Brain Dev; 2013 Feb; 35(2):128-32. PubMed ID: 22874529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnoses commonly missed in childhood. Long-term outcome and implications for treatment.
    Burger FL; Lang CM
    Psychiatr Clin North Am; 1998 Dec; 21(4):927-40, viii. PubMed ID: 9890131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological biomarkers of diagnosis and outcome in neurodevelopmental disorders.
    Jeste SS; Frohlich J; Loo SK
    Curr Opin Neurol; 2015 Apr; 28(2):110-6. PubMed ID: 25710286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Children and adolescents with developmental disabilities. The spectrum of disorders requires a care team with broad competence].
    Fernell E; Gillberg C
    Lakartidningen; 2007 Apr 4-17; 104(14-15):1126-7. PubMed ID: 17472100
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinic attenders with autism or attention-deficit/hyperactivity disorder: cognitive profile at school age and its relationship to preschool indicators of language delay.
    Hagberg BS; Miniscalco C; Gillberg C
    Res Dev Disabil; 2010; 31(1):1-8. PubMed ID: 19713073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between autism spectrum disorders and attention-deficit/hyperactivity disorder: an overview.
    Matson JL; Rieske RD; Williams LW
    Res Dev Disabil; 2013 Sep; 34(9):2475-84. PubMed ID: 23751293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Children and young people with neurodevelopmental problems: Support and efforts must be given even if not all diagnostic criteria are met].
    Fernell E; Landgren M; Lindström K; Johnson M; Gillberg C
    Lakartidningen; 2013 Sep 18-24; 110(38):1674. PubMed ID: 24199445
    [No Abstract]   [Full Text] [Related]  

  • 15. Special issue on developmental delay.
    Levy Y; Ornoy A; Nevo Y
    Dev Disabil Res Rev; 2011; 17(2):57-8. PubMed ID: 23362025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ESSENCE gathers the diagnoses into a whole].
    Gillberg C
    Lakartidningen; 2014 Sep; 111(39):1643-6. PubMed ID: 25253610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mild Sanfilippo syndrome: a further cause of hyperactivity and behavioural disturbance.
    Wraith JE; Danks DM; Rogers JG
    Med J Aust; 1987 Nov; 147(9):450-1. PubMed ID: 3118155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperactivity and behavioral disorders in Sanfilippo A (mucopolysaccharidosis type IIIA)--case report and review of the literature].
    Wolańczyk T; Banaszkiewicz A; Mierzewska H; Czartoryska B; Zdziennicka E
    Psychiatr Pol; 2000; 34(5):831-7. PubMed ID: 11202024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders.
    Rowles BM; Findling RL
    Dev Disabil Res Rev; 2010; 16(3):273-82. PubMed ID: 20981766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The laboratory diagnosis of mucopolysaccharidosis III (Sanfilippo syndrome): A changing landscape.
    Bodamer OA; Giugliani R; Wood T
    Mol Genet Metab; 2014; 113(1-2):34-41. PubMed ID: 25127543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.